OS

Wearable Technology Market to Reach $415.12 Billion by 2029 - Market Sizes, Shares, Forecasts, and Trends Analysis Report with COVID-19 Impact by Meticulous Research®

Retrieved on: 
Wednesday, October 5, 2022

By volume, the global wearable technology market is expected to reach 1,150.71 million units by 2029, at a CAGR of 19.2% during the forecast period.

Key Points: 
  • By volume, the global wearable technology market is expected to reach 1,150.71 million units by 2029, at a CAGR of 19.2% during the forecast period.
  • The COVID-19 pandemic negatively impacted the global wearable technologies market demand due to the shutdown of consumer electronics, automobile, industrial, and other manufacturing facilities across the globe.
  • Quick Buy Wearable Technology Market - Global Opportunity Analysis And Industry Forecast (2022-2029), Research Report: https://www.meticulousresearch.com/Checkout/14849601
    Based on material, the global wearable technology market is segmented into silicones, fluor elastomers, polyurethanes, polymer dispersed liquid crystal (PDLC), and other materials.
  • In 2022, the silicones segment is expected to account for the largest share of the global wearable technologies market.

Wearable Technology Market to Reach $415.12 Billion by 2029 - Market Sizes, Shares, Forecasts, and Trends Analysis Report with COVID-19 Impact by Meticulous Research®

Retrieved on: 
Wednesday, October 5, 2022

By volume, the global wearable technology market is expected to reach 1,150.71 million units by 2029, at a CAGR of 19.2% during the forecast period.

Key Points: 
  • By volume, the global wearable technology market is expected to reach 1,150.71 million units by 2029, at a CAGR of 19.2% during the forecast period.
  • The COVID-19 pandemic negatively impacted the global wearable technologies market demand due to the shutdown of consumer electronics, automobile, industrial, and other manufacturing facilities across the globe.
  • Quick Buy Wearable Technology Market - Global Opportunity Analysis And Industry Forecast (2022-2029), Research Report: https://www.meticulousresearch.com/Checkout/14849601
    Based on material, the global wearable technology market is segmented into silicones, fluor elastomers, polyurethanes, polymer dispersed liquid crystal (PDLC), and other materials.
  • In 2022, the silicones segment is expected to account for the largest share of the global wearable technologies market.

Digital Turbine Makes Strategic Equity Investment in Aptoide

Retrieved on: 
Wednesday, October 5, 2022

AUSTIN, Texas, Oct. 5, 2022 /PRNewswire/ -- Digital Turbine (NASDAQ: APPS), the leading independent mobile growth platform, today announced a strategic investment in Aptoide, one of the largest independent Android app stores, with more than 250 million users. The first step of a strategic commercial relationship between Digital Turbine and Aptoide, this investment leverages technology from each company to build new and innovative distribution products for Digital Turbine's mobile operator, OEM, and app developer clients, paving the way for greater cooperation in the future.

Key Points: 
  • Partnership Advances Digital Turbine's App Distribution Solutions for App Publishers, Operators, and OEMs
    AUSTIN, Texas, Oct. 5, 2022 /PRNewswire/ -- Digital Turbine (NASDAQ: APPS), the leading independent mobile growth platform, today announced a strategic investment in Aptoide , one of the largest independent Android app stores, with more than 250 million users.
  • The first step of a strategic commercial relationship between Digital Turbine and Aptoide, this investment leverages technology from each company to build new and innovative distribution products for Digital Turbine's mobile operator, OEM, and app developer clients, paving the way for greater cooperation in the future.
  • Our investment in Aptoide will deliver our Operators and OEM partners a more curated on-device app experience than what the current one-size-fits all stores can deliver," said Bill Stone, CEO Digital Turbine.
  • Digital Turbine's investment led Aptoide's Series-B funding round of $12M USD, which also included investment from Faurecia, Portugal Ventures, and the 200M Fund, a Portuguese co-investment company.

Apple iOS 16 Adoption Trends: 23% of Users Upgraded Within 3 Weeks of Launch; Pixalate Finds 16.6% Reduction in Ad Fraud on Updated Devices

Retrieved on: 
Tuesday, October 4, 2022

PALO ALTO, Calif. and LONDON, Oct. 4, 2022 /PRNewswire/ -- Pixalate, the market-leading fraud protection, privacy, and compliance analytics platform for Connected TV (CTV) and Mobile Advertising, examined consumer adoption rates surrounding Apple's iOS 16, which debuted on September 16, 2022.*

Key Points: 
  • *
    Pixalate examined open programmatic ad sales on iOS devices from September 1 - 28, 2022 to estimate OS version adoption.
  • Users on newer versions of iOS (iOS 15.5+) were most likely to upgrade to iOS 16.
  • About 1-in-4 iOS 15.5+ users upgraded to the new OS, according to Pixalate's data, while only 1-in-9 iOS 14 users upgraded.
  • Ad fraud rates on devices updated to iOS 16 were 16.6% lower compared to older versions of iOS (14.8% vs. 17.8%).

Cue Biopharma Granted FDA Fast Track Designation for CUE-101 for the Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Retrieved on: 
Tuesday, October 4, 2022

We are very pleased to have received Fast Track designation from the FDA for CUE-101.

Key Points: 
  • We are very pleased to have received Fast Track designation from the FDA for CUE-101.
  • Fast Track is a process designed to facilitate the development and expedite the review of drug candidates to treat serious conditions and fulfill an unmet medical need.
  • A therapeutic candidate that receives Fast Track designation may be eligible for more frequent interactions with the FDA to discuss the therapeutic candidates development plan.
  • Therapeutic candidates with Fast Track designation may be eligible for accelerated approval and priority review if supported by clinical data.

Gradalis to Present at the 2022 Cell & Gene Meeting on the Mesa

Retrieved on: 
Tuesday, October 4, 2022

Location: Oxford Biomedica Ballroom at the Park Hyatt Aviara Resort in Carlsbad, California

Key Points: 
  • Location: Oxford Biomedica Ballroom at the Park Hyatt Aviara Resort in Carlsbad, California
    A replay of the presentation will be available on Gradalis website shortly after the meetings conclusion.
  • Virtual attendance is available which includes a livestream of Gradalis presentation and the ability to view all conference sessions on-demand.
  • Vigil is the first cellular immunotherapy to demonstrate survival benefits in a randomized controlled trial of patients with solid tumors.
  • The company is preparing to initiate a clinical trial intended for product registration in patients with the HRP subtype ovarian cancer.

Fictiv Launches Fictiv Premium to Help Teams Collaborate and Simplify Custom Manufacturing with High Visibility and Control

Retrieved on: 
Tuesday, October 4, 2022

SAN FRANCISCO, Oct. 4, 2022 /PRNewswire/ -- Fictiv, the operating system for custom manufacturing, announced today the commercial availability of Fictiv Premium, a first-of-its-kind paid annual membership program that enables members to coordinate custom manufacturing with high visibility and control—across projects, teams, and entire organizations.

Key Points: 
  • SAN FRANCISCO, Oct. 4, 2022 /PRNewswire/ -- Fictiv , the operating system for custom manufacturing, announced today the commercial availability of Fictiv Premium, a first-of-its-kind paid annual membership program that enables members to coordinate custom manufacturing with high visibility and controlacross projects, teams, and entire organizations.
  • As a result, engineering and supply chain teams must be more agile to address increasingly dynamic workflows.
  • Fictiv Premium provides the digital infrastructure required to keep teams in sync and in control, allowing mechanical engineers, engineering leaders, and purchasing managers to work productively and cohesively.
  • Early Fictiv Premium member Calder Hughes, co-founder and president of FlightHouse Engineering says, "Fictiv Premium has been a game-changer for us regarding team collaboration within our organization.

Gradalis Announces Publication of Two Studies Demonstrating the Positive Results of Vigil® in Combination with Checkpoint Inhibitors

Retrieved on: 
Monday, October 3, 2022

DALLAS, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Gradalis, Inc., a privately held, late-stage clinical biotechnology company, today announced a peer-reviewed publication in Clinical Medicine Insights: Oncology demonstrating positive results from a pilot study investigating Vigil® in combination with a PD-L1 checkpoint inhibitor, durvalumab (Imfinzi® - AstraZeneca), in patients with advanced triple negative breast cancer (TNBC) or recurrent/refractory ovarian cancer (OC). This study also suggests that administration of Vigil with durvalumab improved progression free survival (PFS) in patients with PD-L1 positive tumors compared to those with PD-L1 negative tumors.

Key Points: 
  • Vigil is the first cellular immunotherapy to demonstrate survival benefits in a randomized controlled trial of patients with solid tumors.
  • John Nemunaitis, M.D., Chief Scientific Officer of Gradalis commented, These two clinical trials underscore the therapeutic utility of combining Vigil and checkpoint inhibitors without generating incremental toxicity relative to that shown with single agent checkpoint inhibitor therapy.
  • Vigil in combination with durvalumab demonstrated no grade 3 or greater adverse events that were attributed to Vigil by the investigators.
  • Vigil is being studied in other cancer types and has shown positive results in combination with checkpoint inhibitors.

MobiDev Shares AR App Technology Guide

Retrieved on: 
Friday, September 30, 2022

MobiDev experts shared their vision on augmented reality development in 2022, including the choice of technologies and the development flow.

Key Points: 
  • MobiDev experts shared their vision on augmented reality development in 2022, including the choice of technologies and the development flow.
  • Mobile AR is a prime target for business applications, because smartphones are prevalent in the market and extremely portable.
  • You can find more details on AR App Technologies here:
    MobiDev is an international software engineering company with offices in Poland and Ukraine.
  • MobiDev invests into technology research and has years of experience building AI-powered solutions, implementing machine learning, augmented reality, and IoT.

Mavenir to Deliver Cloud-Based 5G Solutions on Google Cloud

Retrieved on: 
Friday, September 30, 2022

Mavenir announces integration of cloud-native 5G solutions with public cloud infrastructure on Google Cloud, expanding on Mavenirs One Network, Any Cloud All Software strategy.

Key Points: 
  • Mavenir announces integration of cloud-native 5G solutions with public cloud infrastructure on Google Cloud, expanding on Mavenirs One Network, Any Cloud All Software strategy.
  • Validation of Mavenirs Open RAN product in Google Cloud allows CSPs to deploy Mavenirs 5G Open RAN products with Google Distributed Cloud Edge, global infrastructure and state-of-the-art unified container platform Anthos.
  • As an innovative ISV in 5G products and solutions, Mavenir continues to expand and optimize its offerings of fully end-to-end 5G network systems.
  • Were delighted to collaborate with Mavenir to offer Open RAN solutions for 5G networks, said Amol Phadke, GM: Global Telecom Industry, Google Cloud.